NewAmsterdam Pharma Co N.V.·4

Jan 6, 5:54 PM ET

Audet Juliette Berangere 4

4 · NewAmsterdam Pharma Co N.V. · Filed Jan 6, 2025

Insider Transaction Report

Form 4
Period: 2025-01-02
Transactions
  • Award

    Option (right to buy)

    2025-01-02+100,000100,000 total
    Exercise: $25.96Exp: 2035-01-02Ordinary Shares (100,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying the option will vest on January 2, 2026, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through such date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4